Literature DB >> 8646958

Unilateral pudendal neuropathy. Impact on outcome of anal sphincter repair.

Y P Sangwan1, J A Coller, R C Barrett, P L Roberts, J J Murray, L Rusin, D J Schoetz.   

Abstract

PURPOSE: Our purpose was to study the effect of unilateral pudendal neuropathy on the results of anal sphincter repair.
METHOD: Fifteen female patients who underwent external sphincter repair for fecal incontinence were studied. In all instances, incontinence was the result of obstetric delivery injury. Anal manometry and neurophysiologic investigations to document sphincter defects and pudendal neuropathy were performed in all patients. Sphincter repair was performed using an overlapping suture technique.
RESULTS: All patients had anterior sphincter defects. Seven patients (47 percent) had pudendal neuropathy: six (85 percent) had unilateral neuropathy, and one (15 percent) had bilateral neuropathy. Six patients (40 percent) had excellent results; three (20 percent) had good results; four (27 percent) were improved; two (13 percent) experienced no improvement after sphincter repair. All patients with excellent results had normal pudendal nerve terminal motor latency on both sides. Of the three patients with good results, one patient had unilateral pudendal neuropathy. The patients in the remaining two groups (improved and failed) had unilateral (six patients) or bilateral (one patient) pudendal neuropathy.
CONCLUSION: We conclude that both pudendal nerves must be intact to achieve normal continence after sphincter repair. Patients with unilateral pudendal neuropathy are more likely to have poor than to have good postoperative function.

Entities:  

Mesh:

Year:  1996        PMID: 8646958     DOI: 10.1007/bf02056951

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  10 in total

Review 1.  Fecal incontinence: a review.

Authors:  Nicolas Bellicini; Peter J Molloy; Phillip Caushaj; Pamelasue Kozlowski
Journal:  Dig Dis Sci       Date:  2007-05-23       Impact factor: 3.199

2.  Laterality effects of human pudendal nerve stimulation on corticoanal pathways: evidence for functional asymmetry.

Authors:  S Hamdy; P Enck; Q Aziz; S Uengoergil; A Hobson; D G Thompson
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

Review 3.  Fecal incontinence - Challenges and solutions.

Authors:  Nallely Saldana Ruiz; Andreas M Kaiser
Journal:  World J Gastroenterol       Date:  2017-01-07       Impact factor: 5.742

4.  Anal manometric parameters: predictors of outcome following anal sphincter repair?

Authors:  Susan Gearhart; Tracy Hull; Crina Floruta; Tom Schroeder; Jeff Hammel
Journal:  J Gastrointest Surg       Date:  2005-01       Impact factor: 3.452

5.  Does preoperative anal physiology testing or ultrasonography predict clinical outcome with sacral neuromodulation for fecal incontinence?

Authors:  Yarini Quezada; James L Whiteside; Tracy Rice; Mickey Karram; Janice F Rafferty; Ian M Paquette
Journal:  Int Urogynecol J       Date:  2015-05-28       Impact factor: 2.894

Review 6.  Anal incontinence-sphincter ani repair: indications, techniques, outcome.

Authors:  Susan Galandiuk; Leslie A Roth; Quincy J Greene
Journal:  Langenbecks Arch Surg       Date:  2008-05-06       Impact factor: 3.445

7.  Overlapping sphincteroplasty: is it the standard of care?

Authors:  Laura H Goetz; Ann C Lowry
Journal:  Clin Colon Rectal Surg       Date:  2005-02

8.  Evaluation of anal incontinence: minimal approach, maximal effectiveness.

Authors:  Harry T Papaconstantinou
Journal:  Clin Colon Rectal Surg       Date:  2005-02

9.  Pudendal nerve testing does not contribute to surgical decision making following anorectal testing in patients with faecal incontinence.

Authors:  Edward A Cooper; Katie J De-Loyde; Christopher J Young; Heather L Shepherd; Caroline Wright
Journal:  Int J Colorectal Dis       Date:  2016-06-11       Impact factor: 2.571

10.  Laparoscopic Burch colposuspension and overlapping sphincteroplasty for double incontinence.

Authors:  J W Ross
Journal:  JSLS       Date:  2001 Jul-Sep       Impact factor: 2.172

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.